H.C. Wainwright analyst Oren Livnat lowered the firm’s price target on Pacira to $69 from $76 and keeps a Buy rating on the shares. The analyst reduced estimates on macro headwinds, but believes this is more than priced into the stock. It expects the company’s 2023 guidance in late February will bring an "important estimate reset."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PCRX: